Liquidia Corp. (LQDA)
66.74
-1.11
(-1.64%)
USD |
NASDAQ |
Sep 11, 16:00
66.51
-0.23
(-0.34%)
After-Hours: 20:00
Liquidia Price : 66.74 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 68.66 | 69.94 | 66.68 | 66.74 | 778799.0 |
| Sep 10, 2026 | 67.87 | 68.35 | 66.62 | 67.85 | 955032.0 |
| Sep 09, 2026 | 67.39 | 69.38 | 67.35 | 69.12 | 997253.0 |
| Sep 08, 2026 | 68.00 | 69.21 | 67.07 | 67.68 | 1.330M |
| Sep 04, 2026 | 67.91 | 69.46 | 67.40 | 68.66 | 902384.0 |
| Sep 03, 2026 | 69.27 | 70.75 | 68.15 | 68.63 | 932021.0 |
| Sep 02, 2026 | 67.40 | 70.13 | 66.73 | 69.68 | 1.283M |
| Sep 01, 2026 | 67.70 | 69.00 | 66.10 | 66.91 | 1.410M |
| Aug 31, 2026 | 67.10 | 68.27 | 66.10 | 68.17 | 1.055M |
| Aug 28, 2026 | 69.99 | 70.30 | 67.57 | 67.69 | 926770.0 |
| Aug 27, 2026 | 71.01 | 71.70 | 69.51 | 69.94 | 550111.0 |
| Aug 26, 2026 | 70.14 | 72.96 | 70.00 | 71.36 | 846140.0 |
| Aug 25, 2026 | 71.50 | 73.07 | 70.10 | 70.49 | 931109.0 |
| Aug 24, 2026 | 67.77 | 71.11 | 67.25 | 70.27 | 1.291M |
| Aug 21, 2026 | 70.91 | 71.13 | 68.05 | 68.62 | 1.701M |
| Aug 20, 2026 | 73.55 | 74.53 | 70.85 | 71.05 | 1.583M |
| Aug 19, 2026 | 74.99 | 76.65 | 73.29 | 75.33 | 1.156M |
| Aug 18, 2026 | 76.20 | 76.77 | 72.83 | 74.33 | 1.449M |
| Aug 17, 2026 | 73.26 | 77.93 | 73.00 | 77.70 | 1.521M |
| Aug 14, 2026 | 71.98 | 76.90 | 71.53 | 74.44 | 2.517M |
| Aug 13, 2026 | 79.67 | 80.83 | 71.86 | 72.10 | 4.332M |
| Aug 12, 2026 | 83.64 | 86.91 | 78.34 | 78.79 | 3.991M |
| Aug 11, 2026 | 90.83 | 93.61 | 87.00 | 88.05 | 1.871M |
| Aug 10, 2026 | 89.94 | 92.36 | 87.62 | 91.03 | 1.650M |
| Aug 07, 2026 | 89.94 | 91.30 | 88.22 | 90.22 | 562138.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Indivior Pharmaceuticals, Inc. | 34.49 |
| Harmony Biosciences Holdings, Inc. | 41.52 |
| Johnson & Johnson | 265.58 |
| United Therapeutics Corp. | 497.11 |
| Amneal Pharmaceuticals, Inc. | 17.01 |
Price Related Metrics
| PE Ratio | 48.92 |
| PS Ratio | 14.39 |
| Price to Book Value | 30.48 |
| Price to Free Cash Flow | 43.06 |
| Earnings Yield | 2.04% |
| Market Cap | 5.947B |
| Operating PE Ratio | 38.49 |
| Normalized PE Ratio | 48.92 |